Verastem, inc. (VSTM)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Operating activities
Net loss

-149,209

-72,434

-67,802

-36,440

-57,865

-

-

-

-

Net loss

-

-

-

-

-

-53,365

-

-

-

Net loss

-

-

-

-

-

-

-41,202

-31,984

-13,683

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

400

1,000

600

670

754

-

-

-

-

Amortization of acquired intangible asset

1,569

423

-

-

-

-

-

-

-

Amortization of right-of-use asset and lease liability

181

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

427

236

207

83

Stock-based compensation expense

8,539

6,671

5,033

6,287

10,085

12,360

9,676

7,400

1,635

Amortization of deferred financing costs, debt discounts and premiums and discounts on available-for-sale marketable securities

7,131

1,814

223

-

-

-

-

-

-

Change in fair value of interest make whole provision for 2019 Notes

-641

25,556

-

-

-

-

-

-

-

Amortization of deferred financing costs, debt discounts and premiums and discounts on available-for-sale marketable securities

-

-

-

-140

264

-

-

-

-

Amortization of premiums and discounts on available-for-sale marketable securities

-

-

-

-

-

-290

-

-

-

Non-cash expense related to purchase of technology rights

-

-

-

-

-

1,197

-

-1,957

-

Obligation to issue a warrant in exchange for license

-

-

-

-

-

-

-

-

439

Change in fair value of obligation to issue a warrant

-

-

-

-

-

-

-

431

-33

Gain on sale of fixed assets

-

79

-

-

-46

-4

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

2,218

306

-

-

-

-

-

-

-

Inventory

2,769

327

-

-

-

-

-

-

-

Prepaid expenses, other current assets and other assets

877

1,167

943

568

-276

-27

382

376

118

Accounts payable

-598

1,048

5,046

153

863

287

912

-425

1,994

Accrued expenses and other liabilities

-1,707

13,902

577

623

418

2,119

3,738

189

-

Other long-term liabilities

370

500

-

-

-

-

-

-

-

Accrued expenses and deferred rent

-

-

-

-

-

-

-

-

311

Liability classified stock-based compensation awards

-

-

-

-69

-400

-248

717

-

-

Net cash used in operating activities

-138,518

-74,515

-57,310

-29,484

-45,559

-

-

-

-

Investing activities
Net cash used in operating activities

-

-

-

-

-

-36,902

-26,305

-22,601

-9,372

Purchases of property and equipment

7

1,507

-

39

211

2,429

56

310

785

Sales of property and equipment

-

82

-

-

-

-

-

-

-

Acquisition of intangible asset

-

22,000

-

-

-

-

-

-

-

Purchases of investments

94,123

125,452

7,957

-

-

-

-

-

-

Purchase of investments

-

-

-

82,101

199,851

39,361

-

-

-

Maturities of investments

183,743

10,500

51,910

119,067

173,005

85,047

-

-

-

Purchases of investments

-

-

-

-

-

-

118,190

154,028

35,851

Maturities of investments

-

-

-

-

-

-

94,853

108,479

-

Decrease in restricted cash

-

-

-

-41

-

117

-

-

86

Net cash provided by investing activities

89,613

-138,377

43,953

36,968

-27,057

-

-

-

-

Financing activities
Proceeds from long-term debt, net of issuance costs

9,670

9,900

14,811

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

43,140

-23,393

-45,859

-36,722

Deferred debt financing costs

-

-

138

-

-

-

-

-

-

Proceeds from issuance of convertible senior notes, net of issuance costs

-

145,297

-

-

-

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

64,186

Proceeds from the exercise of stock options and employee stock purchase program

569

809

442

-

13

20

33

3

-

Principal payments on the convertible senior notes

12,174

-

-

-

-

-

-

-

-

Interest make-whole payments on the 2019 Notes

438

-

-

-

-

-

-

-

-

Net proceeds from the issuance of common stock and restricted common stock

-

-

-

-

-

-

59,760

57,599

-722

Settlement of restricted stock for tax withholdings

68

-

-

5

417

780

1,302

-

-

Proceeds from the issuance of common stock, net

-

105,156

48,069

-

-

9,534

-

-

-

Proceeds from the issuance of common stock, net

-

-

-

-

63,989

-

-

-

-

Net cash provided by financing activities

-2,441

261,162

63,184

-5

63,585

-

-

-

-

Increase (decrease) in cash, cash equivalents and restricted cash

-51,346

48,270

49,827

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

8,774

58,491

57,602

63,464

Increase (decrease) in cash and cash equivalents

-

-

-

7,479

-9,031

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

15,012

8,793

-10,858

17,370

Supplemental disclosure
Cash paid for interest

12,424

2,107

295

-

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities
Common stock issuance costs included in accounts payable and accrued expenses

15

15

324

-

-

-

-

-

-

Conversion of 2019 Notes into common stock

9,517

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

6

32

Conversion of redeemable convertible preferred stock upon initial public offering

-

-

-

-

-

-

-

68,147

-

Reclassification of obligation to issue warrant from liabilities to equity

-

-

-

-

-

-

-

837

-

Proceeds from the issuance of common stock included in prepaid expenses and other current assets

-

-

-

-

-

2,085

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

-

-

-

-

-

196

-

-

-

Change in fair value of conversion option of Notes on exchange

13,640

-

-

-

-

-

-

-

-